期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

结直肠癌HER-2/neu基因的研究进展 被引量：1

下载PDF
导出
摘要 结直肠癌在北美、西欧、澳洲等经济发达地区十分常见,一般为第2-4位常见癌症。随着我国经济的快速发展,国人的生活方式发生改变,结直肠癌的发病率和死亡率在我国经济发展较快的城市和地区迅速上升,居第四位。
作者 杨悦 万义增
机构地区 辽宁医学院病理教研室 辽宁医学院附属第三医院
出处 《中国医学工程》 2011年第4期165-166,共2页 China Medical Engineering
关键词 HER-2/NEU基因 结直肠癌 经济发达地区 常见癌症 生活方式 经济发展 死亡率 发病率
分类号 R735.37 [医药卫生—肿瘤]
  • 相关文献

参考文献15

  • 1周厚强,沈金辉,吴璇.C-erbB-2在结肠癌的表达及意义[J].基层医学论坛,2005,9(6):481-482. 被引量：2
  • 2Bargmann CI, Hung MC, Weinberg RA. The neu oncogene encodes an epidermal growth factor receptor - related protein [ J ]. Nature, 1986,319(6050) :226 - 230.
  • 3Tapia C, Glatz K, Novotny H, et al. Close association between HER -2 amplification and overexpression in human tumors of non - breast origln[J]. Mod Pathol,2007,20(2) :192 -198.
  • 4Slaman DJ , Clark GM, Wong SG, et al , Human breast cancer: correlation of relapse and survival with amplification of the HER - 2/neu oncogene[ J ]. Science , 1987 ,235 ( 4785 ) : 177 - 182.
  • 5Dykins R , Corbett IP , Henry JA , et al. Long - term survival in breast cancer related to overexpression of the c - erbB - 2 oncopro- study using monoclonal antibody NCL- CB11[ J]. J Pathol,1991,163(2) :105 -110.
  • 6骆成玉,祝学光,等.大肠癌中c—erbB—2基因扩增的研究[J].中国肛肠病杂志,2000,20(10):5-7. 被引量：2
  • 7Klapper LN. Glathe S. Vaisman N. et al. The ErbB - 2/HER2 on- coprotein of human carcinomas may function solely as a shared co- receptor for multiple stroma -derived growth factors[ J]. Proc Nail Acad Sci U S A. 1999,96(9) :4995 -5000.
  • 8王志洁.HER-2/neu癌基因信息传递途径研究进展[J].国外医学（遗传学分册）,2002,25(2):76-80. 被引量：9
  • 9Allgayer H. c - erbB - 2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor - asso- ciated protease systems[ J]. J Clin Oncol,2000,18 ( 11 ) :2201 - 2209.
  • 10Xie Y, Hung MC. Nuclear localization of p185neu tyrosine kinase and its association with transcriptional transaetivation [ J ]. Bio- them Biophys Res Commun, 1994,203 (3) : 1589 - 1598.

二级参考文献52

  • 1Nanashima A, Yamagnchi H, Sawai T, et al. Expression of adhesion molecules in hepatic metastases of colorectal carcinoma: relationship to primary tumours and prognosis after hepatic resection. J Castroenterol Hepatol, 1999, 14: 1004-1009.
  • 2Ishida T. Immunohistochemical expression of CD44 variant 6 in colorectal adenocarcinoma. Surg Today, 2000, 30: 28-32.
  • 3Tannapfel A, Kockerling F, Katalinic A, et al. Expression of nm23H1 predicts lymph node involvement in colorectal carcinoma. Dis Colon Rectum, 1995, 38 : 651-654.
  • 4Forte A, D "Urso A, Gallinaro LS, et al. NM23 expression as prognostic factor in colorectal carcinoma. G Chir, 2002, 23: 61-63.
  • 5Beahrs OH. Staging of cancer of the colon and rectum. Cancer,1992, 70: 1393-1396.
  • 6Hayes DF, Thor AD. c-erbB-2 in breast cancer: development of a clinically useful marker. Semin Oncol, 2002, 29: 231-245.
  • 7Yang JL, Ow KT, Russell PJ, et al. Higher expression of oncoproteins c-myc, c-erbB-2/neu, PCNA, and p53 in metastasizing colorectal cancer than in nonmetastasizing tumors. Ann Surg Oncol,1996, 3: 574-579.
  • 8Nakae S, Shimada E, Urakawa T. Study of c-erbB-2 protein and epidermal growth factor receptor expression and DNA ploidy pattern in colorectal carcinoma. J Surg Oncol, 1993, 54: 246-251.
  • 9Morrin M, Delaney PV. CD44v6 is not relevant in colorectal tumour progression. Int J Colorectal Dis, 2002, 17 : 30-36.
  • 10Chun SY, Bae OS, Kim JB. The significance of CD44 variants expression in colorectal cancer and its regional lymph nodes. J Korean Med Sci, 2000, 15: 696-700.

共引文献39

同被引文献10

  • 1Karapetis CS, Khambata-Ford $,Jonker DJ,et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med, 2008,359 : 1757-1765.
  • 2Zolota V, Batistatou A, Tsamandas AC, et al expression of TGF-betal, p21WAF1, p53, Ki67, and angiogenesis in gastric carcinomas:a clinicopathologic study. Int J Gastrointest Canc- er,2002,32:83-89.
  • 3Wolff AC, Hammond ME, Schwartz JN, et al. American society of clin- ical oncology/college of American pathologists guideline recommenda- tions for human epidermal growth factorreceptor 2 testing in breast cancer. Arch Pathol Lab Med,2007,131:18-43.
  • 4Mayer A, Takimoto M, Fritz E, et al. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer, 1993, 71: 2454-2460.
  • 5Park DI, Kang MS, Oh SJ, et al. HER-2/neu overexpression is an in- dependent prognostic factor in colorectal cancer. Int J Colorectal Dis, 2007,22:491-497.
  • 6PadiUa D, Cubo T, ViUarejo P, et al. Molecular profile of node-nega- tive colorectal cancer of poor prognosis using immunohistochemical de- termination of p53 ,ki67 ,VEGF and metalloproteinase-9. Rev Esp En- fern Dig,2007,99:424-425.
  • 7Bura M, Seiverth S, Vladika I, et al. Possible prognostic significance of p53 and Ki67 in inverted sinonasal papilkma. Coil Antropol, 2007, 31:545-549.
  • 8Forones NM, Oshima C, Nanogaki S, et al. Determination of prolifera- tive activity using ki67 and expression of p53 in eoloreetal cancer. Arq Gastroenterol, 1999,36 : 122-126.
  • 9Saleh HA, Jackson H, Banerjee M. Immunohistochemical expression of bcl-2 and p53 oncoproteins:correlation with Ki67 proliferation index and prognostic histopathologic parameters in colorectal neoplasia. Appl Immunohistochem Mol Morphol,2000,8 : 175-182.
  • 10Horinaka A, Naya K. The transformations of tepene ketones by oxygen. I. The autoxidation of fukinone[J]. Bull Chem Soc Jpn, 1979,52(7): 1964.

引证文献1

二级引证文献9

中国医学工程
2011年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部